Recent modifications of wild bird’s migration patterns and likely genetic mutations of the Avian Influenza virus have increased its capacity replicate and to infect a broader range of bird species and mammals. Increasing the risk of viral transmission to humans.
During the season 2021-2022, a record-breaking number of cases have been reported in Europe and in the United States, where the disease may have become endemic, and more than 100 million birds have been culled. Several technological and trade challenges are hindering the acceptance of vaccines as control tools. However, given that the spread of the disease shows no signs of slowing down and the increasing unacceptance for mass animal culling interventions, the European commission is exploring the possibility of developing a vaccination strategy and discussing the acceptability of vaccination in international trade.
See attached document for an overview of the Global situation related to Avian Influenza.
The TAFS forum is seeking new members. If you are interested, please contact us and describe what you might be able to contribute to the TAFS forum. We look forward to hearing from you.
